Does ALOGLIPTIN Cause Off label use? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Off label use have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 0.9% of all adverse event reports for ALOGLIPTIN.
12
Reports of Off label use with ALOGLIPTIN
0.9%
of all ALOGLIPTIN reports
1
Deaths
3
Hospitalizations
How Dangerous Is Off label use From ALOGLIPTIN?
Of the 12 reports, 1 (8.3%) resulted in death, 3 (25.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN Cause?
Pemphigoid (98)
Pancreatitis (66)
Diarrhoea (60)
Nausea (60)
Rash (55)
Hypoglycaemia (46)
Vomiting (44)
Pancreatitis acute (43)
Drug ineffective (42)
Pruritus (42)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ALOGLIPTIN Alternatives Have Lower Off label use Risk?
ALOGLIPTIN vs ALOGLIPTIN\METFORMIN
ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN vs ALOSETRON
ALOGLIPTIN vs ALPELISIB
ALOGLIPTIN vs ALPHA.-LIPOIC ACID